Biomerica (BMRA) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -7,349.00 |
| Nov 30, 2025 | 1,552.00 |
| Aug 31, 2025 | 14,444.00 |
| May 31, 2025 | -17,548.00 |
| Feb 28, 2025 | -3,114.00 |
| Nov 30, 2024 | -2,785.00 |
| Aug 31, 2024 | -3,028.00 |
| May 31, 2024 | -6,142.00 |
| Feb 29, 2024 | -13,438.00 |
| Nov 30, 2023 | -6,386.00 |
| Aug 31, 2023 | -2,925.00 |
| May 31, 2023 | -10,431.00 |
| Feb 28, 2023 | -12,192.00 |
| Nov 30, 2022 | -9,300.00 |
| Aug 31, 2022 | -11,212.00 |
| May 31, 2022 | -913.00 |
| Feb 28, 2022 | 1,895.00 |
| Nov 30, 2021 | -1,000.00 |
| Aug 31, 2021 | -11,759.00 |
| May 31, 2021 | -14,200.00 |
| Feb 28, 2021 | -3,953.00 |
| Nov 30, 2020 | -10,740.00 |
| Aug 31, 2020 | -13,846.00 |
| May 31, 2020 | -2,629.00 |
| Feb 29, 2020 | -6,285.00 |
| Nov 30, 2019 | -940.00 |
| Aug 31, 2019 | -2,113.00 |
| May 31, 2019 | -6,222.00 |
| Feb 28, 2019 | -5,624.00 |
| Nov 30, 2018 | -577.00 |
| Aug 31, 2018 | -1,895.00 |
| May 31, 2018 | -5,755.00 |
| Feb 28, 2018 | -1,947.00 |
| Nov 30, 2017 | -2,985.00 |
| Aug 31, 2017 | -3,272.00 |
| May 31, 2017 | -2,992.00 |
| Feb 28, 2017 | -3,394.00 |
| Nov 30, 2016 | -2,623.00 |
| Aug 31, 2016 | -1,230.00 |
| May 31, 2016 | -2,827.00 |
| Feb 29, 2016 | -2,455.00 |
| Nov 30, 2015 | -152.00 |